drugset / Trial / NCT02893618
A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)
RandomizedCrossoverOpen-labelTreatment
Summary
Open label, parallel-group, single site, 5 treatment-period study with 4 dose levels of DCCR, 1 of which is administered both with and without food.
Timeline
- Start
- 2017-07
- Primary completion
- 2017-10
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diazoxide | Unknown | 75 mg | — |
| Subject | Diazoxide | Unknown | 150 mg | — |
| Subject | Diazoxide | Unknown | 300 mg | — |
| Subject | Diazoxide | Unknown | 450 mg | — |